Pluristem Therapeutics receives FDA orphan drug designation Pluristem Therapeutics received FDA orphan drug designation for allogeneic ex-vivo expanded placental adherent stromal cells. Reference Link
News For PSTI From The Last 14 Days
Check below for free stories on PSTI the last two weeks.